Startup SetPoint Medical has demonstrated “significant, sustained improvement” over two years in a first-in-human study using bioelectronic therapy in patients with rheumatoid arthritis (RA). Seventeen subjects with moderate to severe symptoms were implanted with a vagus nerve stimulator in the European study. At three months, the therapy was shown to have significantly reduced RA symptoms […]
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
SetPoint Medical launches arthritis neurostim study
SetPoint Medical said today it launched the pilot trial of its neurostimulation device, looking to explore the system’s ability to to treat patients with drug refractory rheumatoid arthritis. The device is designed to be surgically placed on the vagus nerve to activate the body’s natural inflammatory reflex, the Valencia, Calif.-based company said. “Despite the effectiveness […]
SetPoint Medical wins FDA IDE trial nod for rheumatoid arthritis implant trial
SetPoint Medical said today it won FDA investigational device exemption clearance to launch a trial of its proprietary bioelectronic device designed to treat patients with drug refractory rheumatoid arthritis. The device is designed to be surgically placed on the vagus nerve to activate the body’s natural inflammatory reflex, the Valencia, Calif.-based company said. “We are ready to […]
Boston Scientific, Medtronic join $30m SetPoint Medical Series D
SetPoint Medical said today it raised $30 million in a Series D equity financing round with funds slated to support continued development of its bioelectronic therapy for treating chronic inflammatory diseases. Funding in the round came from existing investors including NEA, Morgenthaler, Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), Topspin, Action Potential Venture Capital, the Valencia, Calif.-based company said. “We […]
Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
New Enterprise Associates gets in on SetPoint Medical
SetPoint Medical said today that it has received an investment from venture capital firm New Enterprise Associates. SetPoint is developing a neuromodulation device designed to stimulate the vagus nerve to trigger the body’s anti-inflammatory response, according to the company. Newly vested NEA joins existing investors Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital […]
SetPoint adds $15m to Series C, gets backing by GlaxoSmithKline
SetPoint said today it raised $15 million in an extension of its Series C round of equity financing and added GlaxoSmithKline (NYSE:GSK)’s Action Potential Venture Capital to its list of investors. The funds from the round are slated to support clinical trials of the company’s bioelectronic therapy for treating rheumatoid arthritis and Crohn’s Disease and […]
Boston Scientific, Covidien get in on SetPoint Medical’s $27M round
SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.
MassDevice Network
@MassDevice
LinkedIn
Google+